BusinessActinium Pharmaceuticals Announces Activation of Fifteenth Clinical Trial Site in the Phase 3 SIERRA Trial for Iomab-BBy Nasdaq OMXOct 25, 2017, 11:30 AM UTC
BusinessActinium Pharmaceuticals to Present at BIO Investor ForumBy Nasdaq OMXOct 16, 2017, 11:30 AM UTC
BusinessActinium Pharmaceuticals Provides Update on Actimab-A Phase 2 Clinical Trial for Patients with Acute Myeloid LeukemiaBy Nasdaq OMXOct 4, 2017, 11:30 AM UTC
BusinessActinium Pharmaceuticals to Participate in American Society for Blood and Marrow Transplantation 2017 Corporate Council MeetingBy Nasdaq OMXSep 20, 2017, 11:30 AM UTC
BusinessActinium Pharmaceuticals Highlights Presence at the Society of Hematologic Oncology 2017 Annual MeetingBy Nasdaq OMXSep 13, 2017, 11:30 AM UTC
BusinessActinium to Present at The Rodman & Renshaw 19th Annual Global Investment ConferenceBy Nasdaq OMXSep 6, 2017, 8:05 PM UTC
BusinessActinium Pharmaceuticals to Participate in the Oppenheimer & Co. Boston Oncology Insights Summit on August 16-17, 2017By Nasdaq OMXAug 9, 2017, 11:30 AM UTC
BusinessActinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common StockBy Nasdaq OMXAug 2, 2017, 8:05 PM UTC
